Corporate Information And Statement Of Ifrs Compliance [Abstract]

aap Implantate AG - Filing #6496623

Concept	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	aap	—
Domicile of entity	—	Berlin	—
Legal form of entity	—	AG	—
Country of incorporation	—	Deutschland	—
Address of entity's registered office	—	12099 Berlin, Lorenzweg 5	—
Description of nature of entity's operations and principal activities	—	Der Konzern ist ein Unternehmen der Medizintechnik-	—
Statement of IFRS compliance [text block]	—	Der Konzernabschluss der	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	4,517 EUR	—	7,819 EUR
Current trade payables	2,167 EUR	—	2,084 EUR
Disclosure of material accounting policy information [text block]	—	Die Konzernkapitalflussrechnung wurde in Übereinstimmung mit IAS 7 nach der indirekten Methode	—
Explanation of sources of estimation uncertainty with significant risk of causing material adjustment	—	C. Wesentliche Ermessensentscheidungen, Schätzungen und Annahmen	—
Disclosure of objectives, policies and processes for managing capital [text block]	—	4. Kapitalmanagement	—